Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis | Zendy

Shenglei Li | Zendy; Hongtao Liu | Zendy; Changying Diao | Zendy; Xiaohui Wang | Zendy; Ming Gao | Zendy; Zongming Li | Zendy; Lijie Song | Zendy; Xianzheng Gao | Zendy; Jing Han | Zendy; Feng Wang | Zendy; Wencai Li | Zendy; Xinwei Han | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis

Author(s) -

Shenglei Li,

Hongtao Liu,

Changying Diao,

Xiaohui Wang,

Ming Gao,

Zongming Li,

Lijie Song,

Xianzheng Gao,

Jing Han,

Feng Wang,

Wencai Li,

Xinwei Han

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.16193

Subject(s) - medicine , esophageal cancer , meta analysis , chemoradiotherapy , radiation therapy , oncology , cancer , general surgery

This network meta-analysis was conducted to assess whether the efficacy of surgery with adjuvant therapies, including radiotherapy (RT+S), chemotherapy (CT+S), and chemoradiotherapy (CRT+S) have better performance in esophageal cancer treatment and management. PubMed and EMBASE were used to search for relevant trials. Both conventional pair-wise and network meta-analyses were carried out. The surface under the cumulative ranking curve (SUCRA) was used to rank interventions based on the efficacy of the treatment method. As for 3-year overall survival (OS), CRT+S showed the highest efficacy (CRT+S vs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research